Ocrelizumab-Induced Severe Colitis
Hsing Hwa Lee, Naveen Sritharan, Daniel P. Bermingham, Gabriela Strey
Abstract
We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis.
Topics & Concepts
OcrelizumabMedicineColectomyColitisUlcerative colitisInternal medicineMonoclonal antibodyMultiple sclerosisGastroenterologyRituximabImmunologyAntibodyLymphomaDiseaseMicroscopic ColitisInflammatory Bowel DiseaseLiver Diseases and Immunity